BCMA Targeted Therapies
Evvnt Promotion / evvnt
12.07.2022 - 14.07.2022 The Bostonian, 26 North Street, 02109 Boston, Massachusetts, USA
Time: 9:00 AM - 4:30 PM
Conference themes
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
There aren’t many targets like BCMA - well validated, preferentially expressed by mature B lymphocytes and specific to multiple myeloma – meaning that novel drugs against BCMA continue to emerge. This brings with it an unmatched therapeutic and commercial opportunity for multiple myeloma patients, a large proportion of whom continue to experience poor tolerability, duration of response and develop resistance.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Enquiries and Registration:
https://go.evvnt.com/1093163-2?pid=4832
Mr. Hanson Wade
General Medicine
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
